510(k) · Cleared
ClearedMeRT System
Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly
Wave Neuroscience · SIG Transcranial Magnetic Stimulation System For Post Traumatic Stress Disorder (Ptsd)
Cleared on Jun 3, 2026 as substantially equivalent to K251119 (Tonica Elektronik A/S, 2025) after a 117-day review. Its family tree reaches back 12 generations to 2008.
- Decided
- Jun 3, 2026
- Review
- 117 days
- Class
- Class II
- Product code
- SIG
- Recalls
- None
- Predicates
- 1
Its longest line of descent runs back 12 generations to DEN070003 (2008). 25 ancestors in all. No later device cites it as a predicate yet.
- Root · 12 generations backDEN070003 Neurostar TMS SystemNeuronetics · 2008
- 8 generations between
- 3 generations backK212289 NeuroStar Advanced Therapy for adjunctive treatment of OCD…Neuronetics, Inc. · 2022
- 2 generations backK230029 NeuroStar Advanced Therapy System (Version 3.7)Neuronetics · 2023
- 1 generation backK251119 MagVenture TMS Therapy SystemTonica Elektronik A/S · 2025
- This deviceK260402 MeRT SystemWave Neuroscience · 2026
Show all 12 generations
- Root · 12 generations backDEN070003 Neurostar TMS SystemNeuronetics · 2008
- 11 generations backK083538 Neurostar TMS Therapy System, Model 1.1Neuronetics · 2008 · Recalled
- 10 generations backK130233 Neurostar TMS Therapy SystemNeuronetics · 2013
- 9 generations backK133408 Neurostar TMS Therapy SystemNeuronetics · 2014
- 8 generations backK143531 Rapid Therapy SystemMagstim Company Limited · 2015 · Recalled
- 7 generations backK160309 Neurosoft TMSTeleemg, LLC · 2016
- 6 generations backK171967 MagVita TMS Therapy SystemTonica Elektronik A/S · 2017
- 5 generations backK173620 Mag Vita TMS Therapy System w/Theta Burst StimulationTonica Elektronik A/S · 2018
- 4 generations backK193006 MagVenture TMS Therapy – for treatment of OCD, MagVenture TMS…Tonica Elektronik A/S · 2020
- 3 generations backK212289 NeuroStar Advanced Therapy for adjunctive treatment of OCD…Neuronetics, Inc. · 2022
- 2 generations backK230029 NeuroStar Advanced Therapy System (Version 3.7)Neuronetics · 2023
- 1 generation backK251119 MagVenture TMS Therapy SystemTonica Elektronik A/S · 2025
- This deviceK260402 MeRT SystemWave Neuroscience · 2026
View FIG. 1 as a table
Line of descent and top descendants
| Generation | Number | Device | Applicant | Decided | Recalls |
|---|---|---|---|---|---|
| −12 | DEN070003 | Neurostar TMS System | Neuronetics | 2008 | — |
| −11 | K083538 | Neurostar TMS Therapy System, Model 1.1 | Neuronetics | 2008 | 1 |
| −10 | K130233 | Neurostar TMS Therapy System | Neuronetics | 2013 | — |
| −9 | K133408 | Neurostar TMS Therapy System | Neuronetics | 2014 | — |
| −8 | K143531 | Rapid Therapy System | Magstim Company Limited | 2015 | 3 |
| −7 | K160309 | Neurosoft TMS | Teleemg, LLC | 2016 | — |
| −6 | K171967 | MagVita TMS Therapy System | Tonica Elektronik A/S | 2017 | — |
| −5 | K173620 | Mag Vita TMS Therapy System w/Theta Burst Stimulation | Tonica Elektronik A/S | 2018 | — |
| −4 | K193006 | MagVenture TMS Therapy – for treatment of OCD, MagVenture TMS Therapy system | Tonica Elektronik A/S | 2020 | — |
| −3 | K212289 | NeuroStar Advanced Therapy for adjunctive treatment of OCD, NeuroStar Advanced… | Neuronetics, Inc. | 2022 | — |
| −2 | K230029 | NeuroStar Advanced Therapy System (Version 3.7) | Neuronetics | 2023 | — |
| −1 | K251119 | MagVenture TMS Therapy System | Tonica Elektronik A/S | 2025 | — |
| 0 (this device) | K260402 | MeRT System | Wave Neuroscience | 2026 | — |
Other ancestors by year cleared
| Year cleared | Devices | With a Class I recall |
|---|---|---|
| 2013 | 1 | 0 |
| 2015 | 1 | 0 |
| 2016 | 2 | 0 |
| 2017 | 3 | 0 |
| 2018 | 2 | 0 |
| 2019 | 1 | 0 |
| 2020 | 1 | 0 |
| 2021 | 1 | 0 |
| 2022 | 1 | 0 |
Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.
Planning a device in SIG? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.
- Candidate predicates for a device like this, rankedin the report
- Recall history across each candidate’s familyin the report
What was it cleared against? (1)
Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.
| Type | Number | Device | Decided |
|---|---|---|---|
| * | K251119 | MagVenture TMS Therapy SystemSummary page 5…tric disorders and conditions Classification: II Regulation: 21 CFR 882.5802 Product Code: SIG Predicate Device: K251119 MagVenture TMS Therapy System Description of Device: The MeRT (Magnetic EEG/ECG Resonance Therapy) System has two components: th… | 2025 |
| † | K180173 | Freespira | 2018 |
What descends from it?
No later submission names this one as a predicate yet.
Has anything in its family been recalled? (0 Class I)
No FDA recall names this device.
No ancestor or descendant has a Class I recall.
What does this lineage say?
- The line of descent spans 18 years and passes through 6 companies; a new generation was cleared every 1.1 years on median.
- 2 of the 25 ancestors have a recall of any class.
- 2 other devices also cite its predicate K251119.
How does its category compare?
All SIG devicesSIG Transcranial Magnetic Stimulation System For Post Traumatic Stress Disorder (Ptsd): FDA decisions, review times, recalls and adverse event reports over 20 years. 2026, this device’s year, is highlighted.
FDA decisions per year · SIG
1so far in 2026, the most since 2007
2026 to Oct 25, outlined.
Median 510(k) review, days · SIG
Too few SIG 510(k)s in any year since 2007 to give a median.
Recalls per year · SIG
No recall names SIG since 2007.
Adverse event reports per year · SIG
No MAUDE report names SIG since 2007.
View these four charts as a table
| Year | Decisions | Median 510(k) review, days | Recalls (Class I) | MAUDE reports |
|---|---|---|---|---|
| 2007 | 0 | — | 0 | 0 |
| 2008 | 0 | — | 0 | 0 |
| 2009 | 0 | — | 0 | 0 |
| 2010 | 0 | — | 0 | 0 |
| 2011 | 0 | — | 0 | 0 |
| 2012 | 0 | — | 0 | 0 |
| 2013 | 0 | — | 0 | 0 |
| 2014 | 0 | — | 0 | 0 |
| 2015 | 0 | — | 0 | 0 |
| 2016 | 0 | — | 0 | 0 |
| 2017 | 0 | — | 0 | 0 |
| 2018 | 0 | — | 0 | 0 |
| 2019 | 0 | — | 0 | 0 |
| 2020 | 0 | — | 0 | 0 |
| 2021 | 0 | — | 0 | 0 |
| 2022 | 0 | — | 0 | 0 |
| 2023 | 0 | — | 0 | 0 |
| 2024 | 0 | — | 0 | 0 |
| 2025 | 0 | — | 0 | 0 |
| 2026 | 1 | — | 0 | — |
What is it indicated for?
The MeRT System is intended to be used as an adjunct for the treatment of adult patients suffering from
Post Traumatic Stress Disorder (PTSD).
Indications for use read by OCR from a scanned FDA summary, so letters may be misread. Check the PDF before quoting it.
https://510kreport.com/device/K260402 · printed Nov 6, 2026
Cite this page
510(k) Report. “K260402: MeRT System.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K260402
Report an extraction error
Are you the manufacturer?
Record history
- FDA decision record loaded Oct 30, 2026
- Summary read Oct 30, 2026 (extraction version 2d9447fa9ea4)
- Lineage and recalls computed Nov 3, 2026
- Page last updated Nov 3, 2026